A Fetal Fatty-Acid Oxidation Disorder as a Cause of Liver Disease in Pregnant Women
Jamal A. Ibdah, M.D., Ph.D., Michael J. Bennett, Ph.D., Piero Rinaldo, M.D., Ph.D., Yiwen Zhao, B.S., Beverly Gibson, B.S., Harold F. Sims, B.A., and Arnold W. Strauss, M.D.
Background Acute fatty liver of pregnancy and the HELLP syndrome(hemolysis, elevated liver-enzyme levels, and a low plateletcount) are serious hepatic disorders that may occur during pregnancyin women whose fetuses are later found to have a deficiencyof long-chain 3-hydroxyacyl-coenzyme A (CoA) dehydrogenase.This enzyme resides in the mitochondrial trifunctional protein,which also contains the active site of long-chain 2,3-enoyl-CoAhydratase and long-chain 3-ketoacyl-CoA thiolase. We undertookthis study to determine the relation between mutations in thetrifunctional protein in infants with defects in fatty-acidoxidation and acute liver disease during pregnancy in theirmothers.
Methods In 24 children with 3-hydroxyacyl-CoA dehydrogenasedeficiency, we used DNA amplification and nucleotide-sequenceanalyses to identify mutations in the subunit of the trifunctionalprotein. We then correlated the results with the presence ofliver disease during pregnancy in the mothers.
Results Nineteen children had a deficiency only of long-chain3-hydroxyacyl-CoA dehydrogenase and presented with hypoketotichypoglycemia and fatty liver. In eight children, we identifieda homozygous mutation in which glutamic acid at residue 474was changed to glutamine. Eleven other children were compoundheterozygotes, with this mutation in one allele of the -subunitgene and a different mutation in the other allele. While carryingfetuses with the Glu474Gln mutation, 79 percent of the heterozygousmothers had fatty liver of pregnancy or the HELLP syndrome.Five other children, who presented with neonatal dilated cardiomyopathyor progressive neuromyopathy, had complete deficiency of thetrifunctional protein (loss of activity of all three enzymes).None had the Glu474Gln mutation, and none of their mothers hadliver disease during pregnancy.
Conclusions Women with acute liver disease during pregnancymay have a Glu474Gln mutation in long-chain hydroxyacyl-CoAdehydrogenase. Their infants are at risk for hypoketotic hypoglycemiaand fatty liver.
Source Information
From the Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, N.C. (J.A.I., Y.Z.); the Departments of Pathology and Pediatrics, University of Texas Southwestern Medical Center, Dallas (M.J.B.); the Departments of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minn. (P.R.); and the Departments of Pediatrics (B.G., H.F.S., A.W.S.) and Molecular Biology and Pharmacology (A.W.S.), Washington University School of Medicine, St. Louis.
Address reprint requests to Dr. Strauss at St. Louis Children's Hospital, 1 Children's Pl., St. Louis, MO 63110, or at strauss{at}kids.wustl.edu.
English, S. B., Butte, A. J.
(2007). Evaluation and integration of 49 genome-wide experiments and the prediction of previously unknown obesity-related genes. Bioinformatics
23: 2910-2917
[Abstract][Full Text]
Sibai, B. M.
(2007). Imitators of Severe Preeclampsia. Obstet Gynecol
109: 956-966
[Abstract][Full Text]
Debray, F.-G., Lambert, M., Chevalier, I., Robitaille, Y., Decarie, J.-C., Shoubridge, E. A., Robinson, B. H., Mitchell, G. A.
(2007). Long-term Outcome and Clinical Spectrum of 73 Pediatric Patients With Mitochondrial Diseases. Pediatrics
119: 722-733
[Abstract][Full Text]
Kao, H.-J., Cheng, C.-F., Chen, Y.-H., Hung, S.-I., Huang, C.-C., Millington, D., Kikuchi, T., Wu, J.-Y., Chen, Y.-T.
(2006). ENU mutagenesis identifies mice with cardiac fibrosis and hepatic steatosis caused by a mutation in the mitochondrial trifunctional protein {beta}-subunit. Hum Mol Genet
15: 3569-3577
[Abstract][Full Text]
Das, A. M., Illsinger, S., Lucke, T., Hartmann, H., Ruiter, J. P.N., Steuerwald, U., Waterham, H. R., Duran, M., Wanders, R. J.A.
(2006). Isolated Mitochondrial Long-Chain Ketoacyl-CoA Thiolase Deficiency Resulting from Mutations in the HADHB Gene. Clin. Chem.
52: 530-534
[Abstract][Full Text]
Thiele, I. G. I., Niezen-Koning, K. E., van Gennip, A. H., Aarnoudse, J. G.
(2004). Increased Plasma Carnitine Concentrations in Preeclampsia. Obstet Gynecol
103: 876-880
[Abstract][Full Text]
Bok, L. A., Vreken, P., Wijburg, F. A., Wanders, R. J. A., Gregersen, N., Corydon, M. J., Waterham, H. R., Duran, M.
(2003). Short-Chain Acyl-CoA Dehydrogenase Deficiency: Studies in a Large Family Adding to the Complexity of the Disorder. Pediatrics
112: 1152-1155
[Abstract][Full Text]
Shekhawat, P., Bennett, M. J., Sadovsky, Y., Nelson, D. M., Rakheja, D., Strauss, A. W.
(2003). Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases. Am. J. Physiol. Endocrinol. Metab.
284: E1098-E1105
[Abstract][Full Text]
Ch'ng, C L, Morgan, M, Hainsworth, I, Kingham, J G C
(2002). Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut
51: 876-880
[Abstract][Full Text]
Yang, Z., Yamada, J., Zhao, Y., Strauss, A. W., Ibdah, J. A.
(2002). Prospective Screening for Pediatric Mitochondrial Trifunctional Protein Defects in Pregnancies Complicated by Liver Disease. JAMA
288: 2163-2166
[Abstract][Full Text]
Dybul, M., Fauci, A. S., Bartlett, J. G., Kaplan, J. E., Pau, A. K.
(2002). Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV. ANN INTERN MED
137: 381-433
[Abstract][Full Text]
Rahman, T.M., Wendon, J.
(2002). Severe hepatic dysfunction in pregnancy. QJM
95: 343-357
[Abstract][Full Text]
Jaeschke, H., Gores, G. J., Cederbaum, A. I., Hinson, J. A., Pessayre, D., Lemasters, J. J.
(2002). Mechanisms of Hepatotoxicity. Toxicol Sci
65: 166-176
[Abstract][Full Text]
Sarner, L, Fakoya, A
(2002). Acute onset lactic acidosis and pancreatitis in the third trimester of pregnancy in HIV-1 positive women taking antiretroviral medication. Sex. Transm. Infect.
78: 58-59
[Abstract][Full Text]
Chakrapani, A, Cleary, M A, Wraith, J E
(2001). Detection of inborn errors of metabolism in the newborn. Arch. Dis. Child. Fetal Neonatal Ed.
84: 205F-210
[Full Text]
Wang, W., Li, W., Ikeda, Y., Miyagawa, J.-I., Taniguchi, M., Miyoshi, E., Sheng, Y., Ekuni, A., Ko, J. H., Yamamoto, Y., Sugimoto, T., Yamashita, S., Matsuzawa, Y., Grabowski, G. A., Honke, K., Taniguchi, N.
(2001). Ectopic expression of {{alpha}}1,6 fucosyltransferase in mice causes steatosis in the liver and kidney accompanied by a modification of lysosomal acid lipase. Glycobiology
11: 165-174
[Abstract][Full Text]
McCrae, K. R., Bussel, J. B., Mannucci, P. M., Remuzzi, G., Cines, D. B.
(2001). Platelets: An Update on Diagnosis and Management of Thrombocytopenic Disorders. ASH Education Book
2001: 282-305
[Abstract][Full Text]
DREWS, R. E., WEINBERGER, S. E.
(2000). Thrombocytopenic Disorders in Critically Ill Patients. Am. J. Respir. Crit. Care Med.
162: 347-351
[Full Text]
VanWijk, M. J, Kublickiene, K., Boer, K., VanBavel, E.
(2000). Vascular function in preeclampsia. Cardiovasc Res
47: 38-48
[Abstract][Full Text]